Condition: SLC6A1 Neurodevelopmental Disorder (NDD) · Developmental and Epileptic Encephalopathies (DEE) · Sponsor: UCB Biopharma SRL
The overall objective of this prospective longitudinal natural history study is to collect clinical data to characterize and evaluate the natural course of SLC6A1-NDD and assess the feasibility of certain assessments for the purpose of conducting future clinical studies in patients with this disease.
This description comes directly from the study's public registry record.
UCB Cares · +18445992273 · ucbcares@ucb.com
Always discuss trial participation with your own doctor first.
| Gtep01 50614 | New York, New York, United States | Recruiting |
| Gtep01 40131 | Strasbourg, France | Recruiting |
| Gtep01 40870 | Madrid, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07531511